Alpine Immune Sciences Inc (ALPN)
64.65
+0.07
(+0.11%)
USD |
NASDAQ |
May 01, 15:00
Alpine Immune Sciences Price to Book Value: 12.92 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 12.91 |
| April 29, 2024 | 12.93 |
| April 26, 2024 | 12.91 |
| April 25, 2024 | 12.92 |
| April 24, 2024 | 12.91 |
| April 23, 2024 | 12.90 |
| April 22, 2024 | 12.91 |
| April 19, 2024 | 12.90 |
| April 18, 2024 | 12.88 |
| April 17, 2024 | 12.89 |
| April 16, 2024 | 12.89 |
| April 15, 2024 | 12.88 |
| April 12, 2024 | 12.87 |
| April 11, 2024 | 12.87 |
| April 10, 2024 | 9.404 |
| April 09, 2024 | 7.785 |
| April 08, 2024 | 7.703 |
| April 05, 2024 | 6.978 |
| April 04, 2024 | 7.062 |
| April 03, 2024 | 7.617 |
| April 02, 2024 | 7.837 |
| April 01, 2024 | 8.039 |
| March 28, 2024 | 7.923 |
| March 27, 2024 | 7.725 |
| March 26, 2024 | 7.485 |
| Date | Value |
|---|---|
| March 25, 2024 | 7.505 |
| March 22, 2024 | 7.863 |
| March 21, 2024 | 8.315 |
| March 20, 2024 | 8.041 |
| March 19, 2024 | 7.985 |
| March 18, 2024 | 7.089 |
| March 15, 2024 | 7.271 |
| March 14, 2024 | 7.173 |
| March 13, 2024 | 7.317 |
| March 12, 2024 | 7.285 |
| March 11, 2024 | 7.072 |
| March 08, 2024 | 7.181 |
| March 07, 2024 | 7.395 |
| March 06, 2024 | 7.704 |
| March 05, 2024 | 7.488 |
| March 04, 2024 | 7.326 |
| March 01, 2024 | 7.194 |
| February 29, 2024 | 7.038 |
| February 28, 2024 | 6.978 |
| February 27, 2024 | 7.186 |
| February 26, 2024 | 6.944 |
| February 23, 2024 | 6.779 |
| February 22, 2024 | 6.617 |
| February 21, 2024 | 6.073 |
| February 20, 2024 | 6.097 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.307
Minimum
Nov 12 2019
16.86
Maximum
Jul 31 2020
3.741
Average
2.741
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.948 |
| Eliem Therapeutics Inc | 1.901 |
| Regeneron Pharmaceuticals Inc | 3.847 |
| Vera Therapeutics Inc | 23.26 |
| Eyenovia Inc | 4.642 |
Price to Book Value Related Metrics
| PS Ratio | 54.90 |
| Price | 64.65 |
| Earnings Yield | -0.99% |
| Market Cap | 4.238B |